Chinese COVID vaccine developer Clover raised $240 million net proceeds in Hong Kong IPO
BEIJING (Reuters) – Chinese COVID-19 vaccine developer Clover Biopharmaceuticals said on Thursday it raised $240 million in net proceeds in […]
» Read morenohealthproblemsnews.com
Home »
BEIJING (Reuters) – Chinese COVID-19 vaccine developer Clover Biopharmaceuticals said on Thursday it raised $240 million in net proceeds in […] FILE PHOTO: A health worker prepares a dose of the Sinovac’s CoronaVac coronavirus disease (COVID-19) vaccine in San Salvador, El […] FILE PHOTO: People walk near a cherry blossom street, closed to avoid the spread of the coronavirus disease (COVID-19), in […] FILE PHOTO: Tedros Adhanom Ghebreyesus, Director General of the World Health Organization (WHO) speaks during the opening of the 148th […] FILE PHOTO: Vials labelled “Sputnik V Coronavirus COVID-19 Vaccine” and a syringe are seen in front of a displayed Sputnik […] FILE PHOTO: Empty vials of Oxford/AstraZeneca’s COVID-19 vaccine are seen at a vaccination centre in Antwerp, Belgium March 18, 2021. […] BRUSSELS (Reuters) – The European Union is planning to extend its export authorisation scheme for COVID-19 vaccines to the end […] FILE PHOTO: The word “COVID-19” is reflected in a drop on a syringe needle in this illustration taken November 9, […] TOKYO (Reuters) – The first batch of Pfizer Inc’s COVID-19 vaccine arrived in Japan on Friday, local media reported, with […] VELIZY-VILLACOUBLAY, France (Reuters) – Emmanuel Nizard made a 2 million euro bet last year that President Emmanuel Macron’s call for […]
Chinese COVID vaccine developer Clover raised $240 million net proceeds in Hong Kong IPO
Sinovac supplied 260 million COVID-19 vaccine doses globally
South Korea reports 668 new coronavirus cases, highest daily count in three months
Follow-up probe of virus origins expected – WHO's Tedros
Russia says unnamed U.S. firm violated patent rights on Sputnik V vaccine
Georgia limits AstraZeneca shots after nurse dies of anaphylactic shock: TASS
EU to extend COVID-19 vaccine export controls as AstraZeneca shipment blocked: sources
South Africa says J&J, Pfizer, Moderna vaccines considered for 'immediate use'
First COVID-19 vaccines arrive in Japan from Pfizer: media
French mask producers seek protective shield once pandemic over